Yahoo Web Search

Search results

1. • 

     Pfizer's COVID-19 vaccine candidate shown to be 90% effective in early findings

     USA TODAY via Yahoo News· 2 years ago

     In a major boost to vaccine development, Pfizer and its collaborator BioNTech released early study...

2. • 

     Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?

     Zacks via Yahoo Finance· 1 year ago

     We expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...

3. • 

     Pentagon OK's COVID-19 Vaccine that May Ease Some Religious Objections

     Military.com via Yahoo News· 2 years ago

     The Pentagon said Monday it will now offer a new COVID-19 vaccine to the rank and file that claims...

4. • 

     Novavax's COVID-19 Vaccine Gets Complete Approval From European Commission

     Benzinga via Yahoo Finance· 10 months ago

     The European Commission has approved Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373), following...

5. • 

     Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates

     Benzinga via Yahoo Finance· 1 year ago

     Novavax Inc (NASDAQ: NVAX) has initiated a Phase 2 trial for its COVID-19-Influenza Combination...

6. • 

     Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents

     Benzinga via Yahoo Finance· 2 years ago

     Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded...

7. • 

     Novavax Says Initial 1M Doses Of Nuvaxovid COVID-19 Vaccine Are Available In UK

     Benzinga via Yahoo Finance· 2 years ago

     Novavax Inc (NASDAQ: NVAX) announced that an initial one million doses of Nuvaxovid (NVX-CoV2373)...

8. • 

     Novavax (NVAX) COVID-19 Vaccine Gets FDA Nod for Adolescents

     Zacks via Yahoo Finance· 2 years ago

     Post the label expansion by the FDA, Novavax's (NVAX) COVID-19 vaccine is the first protein-based...

9. • 

     Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants

     Benzinga via Yahoo Finance· 2 years ago

     Novavax Inc (NASDAQ: NVAX) presented data from the Phase 3 PREVENT-19 trial and Study 307 (Lot...

10. • 

      FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines

      CBS News via Yahoo News· 2 years ago

      The Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...